biotech · Unresectable or metastatic conventional chondrosarcoma · Advanced or metastatic solid tumors · INBX
Inhibrx Biosciences
Inhibrx Biosciences trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
San Diego, USA HQ
2010 Founded
114 Employees
Public company Type
INBX · NYSE Ticker
Company details
- Status
- Public
- HQ
- San Diego, USA
- Founded
- 2010
- Employees
- 114
- Programs
- 10
- Drugs
- 17
- Patents
- 35
Inhibrx Biosciences clinical trials
Registry index of 10 ClinicalTrials.gov studies linked to Inhibrx Biosciences programs — each row shows trial ID, program name, phase, status, and indication.
Inhibrx Biosciences trial registry — 10 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Inhibrx Biosciences.
-
Ph1 INBRX-109 Part 3 — Phase 2
Clinical update -
Ph2 INBRX-109 SA CS — Phase 2
Clinical update -
INBRX106-01-201 — Phase 3
Clinical update -
INBRX-109 — Phase 2
Clinical update -
INBRX-106 - Hexavalent OX40 agonist antibody — Phase 2
Clinical update -
INBRX-105 - PDL1x41BB antibody — Phase 1
Clinical update -
INBRX-101/rhAAT-Fc — Phase 1
Clinical update -
INBRX-106 — Phase 3
Clinical update